01 12Pfizer Consumer Healthcare, a division of Pfizer Canada Inc
02 2BioSyent Pharma Inc..
01 12570474
02 122764740
03 12955557
01 2ACETAMINOPHEN | IBUPROFEN SODIUM DIHYDRATE
02 12IBUPROFEN SODIUM DIHYDRATE
01 2SOLUTION
02 12TABLET
01 12025-07-07
02 122030-06-21
03 12035-07-17
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE & MIGRAINE PAIN
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE & MIGRAINE PAIN
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE&MIGRAINE PAIN EXTRA STRENGTH CAPLET
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Patent Expiration Date : 2025-07-07
Date Granted : 2010-01-05
ACETAMINOPHEN, IBUPROFEN SODIUM DIHYDRATE
Brand Name : COMBOGESIC IV
Patent Number : 2570474
Filing Date : 2005-07-07
Strength per Unit : 10mg / mL, 3mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-07-07
Date Granted : 2010-01-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-07-17
Date Granted : 2021-06-22
ACETAMINOPHEN, IBUPROFEN SODIUM DIHYDRATE
Brand Name : COMBOGESIC IV
Patent Number : 2955557
Filing Date : 2015-07-17
Strength per Unit : 10mg / mL, 3mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2035-07-17
Date Granted : 2021-06-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE CAPLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE TABLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE EXTRA STRENGTH
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL MIGRAINE TABLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL MIGRAINE EXTRA STRENGHT
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
